Non-fasting blood glucose range is a key concept for understanding diabetes risk and diagnosis in everyday clinical practice. Unlike a fasting test, a random blood glucose measurement can be taken at any time of day, making it a practical tool for GPs and clinicians across the UK. Whether you have received an unexpected result from a pharmacy check, a routine health screen, or a hospital visit, understanding what your reading means — and when it warrants further investigation — is essential. This article explains the UK reference ranges, what raised or low readings may indicate, how random glucose compares to other tests, and when to seek medical advice.

What Is a Non-Fasting Blood Glucose Test?

A non-fasting blood glucose test measures blood glucose at any time of day without prior fasting, and is used in routine or urgent clinical assessments; laboratory venous plasma glucose is required for formal diagnosis, not home glucometers.

A non-fasting blood glucose test — sometimes called a random blood glucose test — measures the level of glucose (sugar) in your blood at any point during the day, regardless of when you last ate or drank. Unlike a fasting glucose test, which requires you to abstain from food and drink (other than water) for at least eight hours beforehand, a non-fasting test can be taken at any time. This makes it a practical and accessible option in many clinical settings.

Healthcare professionals may request a non-fasting blood glucose test as part of a routine health check, during an urgent assessment, or when symptoms suggestive of diabetes or hypoglycaemia are present. Symptoms that might prompt this test include excessive thirst, frequent urination, unexplained fatigue, blurred vision, or episodes of dizziness and shakiness.

The test itself is straightforward. A small blood sample is taken — either via a finger-prick using a glucometer for an immediate bedside reading, or through a venous blood draw sent to a laboratory for a more precise result. It is important to note that for diagnostic purposes, a venous plasma glucose result from an accredited laboratory is required; readings from home finger-prick glucometers or continuous glucose monitors (CGMs) are not considered sufficiently accurate for formal diagnosis and should not be used to confirm or exclude diabetes. Laboratory results are the standard used in UK clinical practice (NICE CKS: Type 2 diabetes).

Non-fasting glucose levels are naturally influenced by recent food and drink intake, physical activity, stress, and certain medications, all of which your GP or clinician will take into account when interpreting your result.

Normal Non-Fasting Blood Glucose Ranges in the UK

In the UK, a random venous plasma glucose of 11.1 mmol/L or above with symptoms is strongly suggestive of diabetes; below this threshold, further testing with HbA1c or fasting plasma glucose is needed if diabetes is suspected.

In the UK, blood glucose is measured in millimoles per litre (mmol/L). For a random (non-fasting) venous plasma glucose test, the key diagnostic threshold used by NHS clinicians is:

• Diabetes likely: 11.1 mmol/L or above — when accompanied by classic symptoms of diabetes (such as increased thirst, frequent urination, unexplained weight loss, or fatigue), a single random plasma glucose at or above this level is strongly suggestive of diabetes. Without symptoms, a repeat confirmatory test on a separate day — or an HbA1c measurement — is required before a diagnosis can be made (NICE CKS: Type 2 diabetes; NICE NG28).

• Below 11.1 mmol/L: A random glucose below this threshold does not rule out diabetes or pre-diabetes. Further investigation with an HbA1c test or fasting plasma glucose is needed if there is clinical concern.

It is important to understand that a random blood glucose test alone cannot be used to diagnose pre-diabetes (impaired glucose tolerance or impaired fasting glucose). These conditions are defined using specific tests: impaired glucose tolerance (IGT) is diagnosed by a 2-hour oral glucose tolerance test (OGTT) result of 7.8–11.0 mmol/L; impaired fasting glucose (IFG) is defined by a fasting plasma glucose of 6.1–6.9 mmol/L (WHO criteria). A single random glucose reading in this range is not diagnostic of pre-diabetes but may warrant formal follow-up testing.

For people already diagnosed with diabetes, Diabetes UK advises that post-meal blood glucose levels (measured approximately two hours after eating) should ideally remain below 8.5 mmol/L, though individual targets are set in discussion with a clinician and will vary depending on treatment, age, and other factors. NICE focuses on HbA1c as the primary measure for ongoing monitoring rather than individual glucose readings.

Children and pregnant women may have different reference ranges, and specific guidance should always be sought from a healthcare professional in these cases.

What Raised or Low Readings May Indicate

A random glucose at or above 11.1 mmol/L may indicate diabetes, though transient causes such as illness, stress, or corticosteroids must be excluded; readings below 4.0 mmol/L indicate hypoglycaemia requiring prompt treatment.

A non-fasting blood glucose reading at or above 11.1 mmol/L may suggest diabetes, but context is essential. Transient elevations can occur after a large carbohydrate-rich meal, during periods of acute illness or infection, following significant physical or emotional stress, or as a side effect of certain medicines. Medicines commonly associated with raised blood glucose include corticosteroids (such as prednisolone), atypical antipsychotics (such as olanzapine and clozapine), and thiazide diuretics (such as bendroflumethiazide). These factors do not necessarily indicate an underlying metabolic condition, but persistent or repeatedly elevated readings warrant further investigation with HbA1c or fasting plasma glucose (BNF; NICE CKS).

A random glucose reading below 11.1 mmol/L but above what would be expected for the individual — particularly if accompanied by symptoms — may indicate impaired glucose regulation. However, a single random reading in the range of 7.8–11.0 mmol/L is not diagnostic of pre-diabetes. If there is clinical concern, your GP will arrange formal testing: an HbA1c, fasting plasma glucose, or a 2-hour oral glucose tolerance test (OGTT). An OGTT result of 7.8–11.0 mmol/L at two hours confirms impaired glucose tolerance (IGT), which is associated with increased risk of developing type 2 diabetes and cardiovascular disease. NICE recommends referral to a structured lifestyle education programme, such as the NHS Diabetes Prevention Programme, for those identified at high risk (NICE PH38).

On the other end of the spectrum, a low blood glucose reading — generally below 4.0 mmol/L — is known as hypoglycaemia. This is more commonly seen in people taking insulin or certain diabetes medicines (such as sulphonylureas), but can occasionally occur in non-diabetic individuals due to prolonged fasting, excessive alcohol consumption, or rare underlying conditions such as insulinoma. Symptoms of hypoglycaemia include sweating, trembling, confusion, palpitations, and in severe cases, loss of consciousness.

If you experience symptoms of hypoglycaemia and are able to swallow safely, the immediate first-aid approach is to take 15–20 g of fast-acting carbohydrate — for example, a small glass of fruit juice, glucose tablets, or sugary (non-diet) fizzy drink — and recheck your blood glucose after 15 minutes. If there is no recovery, or if the person is unconscious or having a seizure, call 999 immediately. Anyone experiencing repeated hypoglycaemic episodes should seek prompt medical review.

If you suspect that a medicine is causing changes to your blood glucose, you or your healthcare professional can report this to the MHRA via the Yellow Card scheme (yellowcard.mhra.gov.uk).

How Non-Fasting Results Compare to Fasting Glucose Tests

Fasting plasma glucose diagnoses diabetes at 7.0 mmol/L or above, while HbA1c of 48 mmol/mol or above is the primary UK diagnostic tool; non-fasting glucose is most useful in urgent or opportunistic settings.

Understanding the difference between non-fasting and fasting glucose tests is important for interpreting results accurately. A fasting plasma glucose (FPG) test requires a minimum of eight hours without food or caloric drinks and provides a baseline measure of how the body regulates glucose in the absence of recent dietary intake. The diagnostic threshold for diabetes using a fasting test is 7.0 mmol/L or above. A fasting plasma glucose of 6.1–6.9 mmol/L indicates impaired fasting glucose (IFG), a form of pre-diabetes (WHO criteria).

The HbA1c test is the primary diagnostic and monitoring tool recommended by NICE and widely used in UK clinical practice. Rather than measuring glucose at a single point in time, HbA1c reflects average blood glucose levels over the preceding two to three months. A result of 48 mmol/mol (6.5%) or above is diagnostic of diabetes, while a result of 42–47 mmol/mol (6.0–6.4%) indicates a high risk of developing diabetes. HbA1c is generally preferred for routine screening and monitoring because it does not require fasting and is less susceptible to short-term fluctuations (NICE NG28).

However, HbA1c is not reliable in certain groups and should not be used for diagnosis in these circumstances. These include:

• Pregnancy (gestational diabetes must be diagnosed using an OGTT)

• People with haemoglobinopathies (such as sickle cell disease or thalassaemia)

• Haemolytic or iron-deficiency anaemia

• Recent blood transfusion

• Chronic kidney disease (CKD) stage 3b or above

• Acute illness

In these situations, fasting plasma glucose or a 2-hour OGTT should be used instead (NICE CKS: Type 2 diabetes).

Non-fasting glucose tests are particularly useful in urgent or opportunistic settings — for example, when a patient presents with symptoms of hyperglycaemia and an immediate result is needed. However, for formal diagnosis, venous plasma glucose (fasting or random, depending on clinical context) or HbA1c is required. For long-term monitoring in people with established diabetes, HbA1c is the standard measure; fasting plasma glucose is primarily a diagnostic alternative when HbA1c is unsuitable. Your GP will determine which test is most appropriate based on your individual circumstances, symptoms, and medical history.

When to Speak to Your GP About Your Blood Glucose Levels

Seek GP advice if a reading is 11.1 mmol/L or above with symptoms, below 4.0 mmol/L without a known diabetes diagnosis, or if you are at high risk and have not had a recent HbA1c or glucose check.

Knowing when to seek medical advice about your blood glucose levels is an important aspect of self-care and early disease detection. You should contact your GP if:

• A home or pharmacy glucose reading is 11.1 mmol/L or above, particularly if you are experiencing symptoms such as increased thirst, frequent urination, unexplained weight loss, or fatigue. If symptoms are marked and the reading is significantly elevated, seek same-day urgent assessment rather than waiting for a routine appointment.

• You have a reading below 4.0 mmol/L and are not known to have diabetes, or if hypoglycaemic episodes are occurring repeatedly.

• You have been told you are at risk of diabetes (for example, due to overweight or obesity, a family history of type 2 diabetes, or a previous diagnosis of gestational diabetes) and have not had a recent blood glucose or HbA1c check.

• You are pregnant and concerned about your glucose levels, as gestational diabetes requires specialist monitoring and must be diagnosed using an oral glucose tolerance test (OGTT), not HbA1c.

It is also worth seeking advice if you are taking medicines known to affect blood glucose — such as long-term corticosteroids, atypical antipsychotics, or thiazide diuretics — and have not had your glucose levels checked recently.

Please note that readings from home glucometers and pharmacy testing devices are not suitable for formal diagnosis; they may prompt you to seek further assessment, but confirmatory laboratory testing is always required. Availability of pharmacy-based glucose testing varies locally.

In an emergency — such as a person who is unconscious, confused, or having a seizure potentially related to very high or very low blood glucose — call 999 immediately.

NICE recommends that adults at high risk of type 2 diabetes should be identified through structured risk assessment (for example, using the QDiabetes risk tool or NHS Health Check) and then offered an HbA1c or fasting plasma glucose test — not routine random glucose screening (NICE PH38). If you are concerned about your risk, speak to your GP or practice nurse, who can arrange appropriate assessment.

Managing Blood Glucose: NHS Guidance and Next Steps

NHS and NICE guidance prioritises lifestyle modification — including diet, physical activity, and weight management — as the cornerstone of blood glucose management, with metformin as first-line pharmacological treatment for type 2 diabetes.

If your non-fasting blood glucose reading is outside the normal range, there are well-established steps that can help bring levels back into a healthy range or prevent further deterioration. The NHS and NICE both emphasise that lifestyle modification is the cornerstone of blood glucose management, particularly for those with pre-diabetes or newly diagnosed type 2 diabetes.

Key lifestyle recommendations include:

• Diet: Reducing intake of refined carbohydrates, sugary drinks, and ultra-processed foods; increasing fibre through vegetables, wholegrains, and legumes; and following a balanced diet in line with the NHS Eatwell Guide.

• Physical activity: Aiming for at least 150 minutes of moderate-intensity aerobic activity per week, alongside muscle-strengthening activities on two or more days per week, in line with the UK Chief Medical Officers' Physical Activity Guidelines.

• Weight management: Even a modest reduction in body weight (5–10%) can significantly improve insulin sensitivity and blood glucose control in those who are overweight.

• Alcohol and smoking: Limiting alcohol intake and stopping smoking, both of which can adversely affect glucose metabolism and cardiovascular risk.

For those diagnosed with type 2 diabetes, NICE guidance (NG28) recommends metformin as the first-line pharmacological treatment in most cases, alongside lifestyle measures. Individual HbA1c targets are agreed between the patient and their clinician, taking into account age, comorbidities, and risk of hypoglycaemia. Additional agents — including SGLT2 inhibitors (such as empagliflozin or dapagliflozin) or GLP-1 receptor agonists — may be considered based on cardio-renal risk factors and whether HbA1c targets are not met, in line with NICE NG28. People with type 1 diabetes require insulin therapy and specialist diabetes team support.

If you experience any suspected side effects from medicines used to manage blood glucose, you are encouraged to report these to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk. Healthcare professionals and patients can both submit reports.

The NHS Diabetes Prevention Programme offers free, evidence-based support for adults in England identified as being at high risk of type 2 diabetes. Referrals can be made by a GP or, in some areas, individuals can self-refer. Regular monitoring, structured education, and ongoing support from a multidisciplinary team are all central to effective long-term blood glucose management.

Frequently Asked Questions